These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25207879)
1. The urinary proteome and metabonome differ from normal in adults with mitochondrial disease. Hall AM; Vilasi A; Garcia-Perez I; Lapsley M; Alston CL; Pitceathly RD; McFarland R; Schaefer AM; Turnbull DM; Beaumont NJ; Hsuan JJ; Cutillas PR; Lindon JC; Holmes E; Unwin RJ; Taylor RW; Gorman GS; Rahman S; Hanna MG Kidney Int; 2015 Mar; 87(3):610-22. PubMed ID: 25207879 [TBL] [Abstract][Full Text] [Related]
2. One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation. Esterhuizen K; Lindeque JZ; Mason S; van der Westhuizen FH; Rodenburg RJ; de Laat P; Smeitink JAM; Janssen MCH; Louw R Metabolomics; 2021 Jan; 17(1):10. PubMed ID: 33438095 [TBL] [Abstract][Full Text] [Related]
3. Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation. de Laat P; Koene S; van den Heuvel LP; Rodenburg RJ; Janssen MC; Smeitink JA J Inherit Metab Dis; 2012 Nov; 35(6):1059-69. PubMed ID: 22403016 [TBL] [Abstract][Full Text] [Related]
4. The clinical characteristics of patients with mitochondrial tRNA Leu(UUR)m.3243A > G mutation: Compared with type 1 diabetes and early onset type 2 diabetes. Zhu J; Yang P; Liu X; Yan L; Rampersad S; Li F; Li H; Sheng C; Cheng X; Zhang M; Qu S J Diabetes Complications; 2017 Aug; 31(8):1354-1359. PubMed ID: 28599824 [TBL] [Abstract][Full Text] [Related]
5. De Novo Mutation of m.3243A>G together with m.16093T>C Associated with Atypical Clinical Features in a Pedigree with MIDD Syndrome. Jiang Z; Zhang Y; Yan J; Li F; Geng X; Lu H; Wei X; Feng Y; Wang C; Jia W J Diabetes Res; 2019; 2019():5184647. PubMed ID: 31143779 [TBL] [Abstract][Full Text] [Related]
6. The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management. Nesbitt V; Pitceathly RD; Turnbull DM; Taylor RW; Sweeney MG; Mudanohwo EE; Rahman S; Hanna MG; McFarland R J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):936-8. PubMed ID: 23355809 [TBL] [Abstract][Full Text] [Related]
7. Renal manifestations in adults with mitochondrial disease from the mtDNA m.3243A>G pathogenic variant. Ferreira F; Gonçalves Bacelar C; Lisboa-Gonçalves P; Paulo N; Quental R; Nunes AT; Silva R; Tavares I Nefrologia (Engl Ed); 2023 Dec; 43 Suppl 2():1-7. PubMed ID: 38355238 [TBL] [Abstract][Full Text] [Related]
8. The heart in m.3243A>G carriers. Finsterer J; Zarrouk-Mahjoub S Herz; 2020 Jun; 45(4):356-361. PubMed ID: 30128910 [TBL] [Abstract][Full Text] [Related]
9. Anatomic & metabolic brain markers of the m.3243A>G mutation: A multi-parametric 7T MRI study. Haast RAM; Ivanov D; IJsselstein RJT; Sallevelt SCEH; Jansen JFA; Smeets HJM; de Coo IFM; Formisano E; Uludağ K Neuroimage Clin; 2018; 18():231-244. PubMed ID: 29868447 [TBL] [Abstract][Full Text] [Related]
10. Obstetric complications in carriers of the m.3243A>G mutation, a retrospective cohort study on maternal and fetal outcome. de Laat P; Fleuren LH; Bekker MN; Smeitink JA; Janssen MC Mitochondrion; 2015 Nov; 25():98-103. PubMed ID: 26455484 [TBL] [Abstract][Full Text] [Related]
11. Intra-patient variability of heteroplasmy levels in urinary epithelial cells in carriers of the m.3243A>G mutation. de Laat P; Rodenburg RJ; Smeitink JAM; Janssen MCH Mol Genet Genomic Med; 2019 Feb; 7(2):e00523. PubMed ID: 30516030 [TBL] [Abstract][Full Text] [Related]
13. MIDD or MELAS : that's not the question MIDD evolving into MELAS : a severe phenotype of the m.3243A>G mutation due to paternal co-inheritance of type 2 diabetes and a high heteroplasmy level. de Wit HM; Westeneng HJ; van Engelen BG; Mudde AH Neth J Med; 2012 Dec; 70(10):460-2. PubMed ID: 23230016 [TBL] [Abstract][Full Text] [Related]
14. Retinopathy in type II diabetes mellitus associated with above-normal urinary excretion of RBP. Holm J; Nielsen NV; Hemmingsen L Kidney Int Suppl; 1994 Nov; 47():S105-8. PubMed ID: 7869657 [TBL] [Abstract][Full Text] [Related]
15. Multimodal imaging analysis of macular dystrophy in patient with maternally inherited diabetes and deafness (MIDD) with m.3243A>G mutation. Oishi N; Kubota D; Nakamoto K; Takeda Y; Hayashi M; Gocho K; Yamaki K; Igarashi T; Takahashi H; Kameya S Ophthalmic Genet; 2021 Jun; 42(3):304-311. PubMed ID: 33541179 [No Abstract] [Full Text] [Related]
16. MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes. Nakamura M; Yabe I; Sudo A; Hosoki K; Yaguchi H; Saitoh S; Sasaki H J Med Genet; 2010 Oct; 47(10):659-64. PubMed ID: 20610441 [TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of Diabetes in People with Mitochondrial DNA 3243A>G Mutation in Korea. Rho EH; Baek SI; Lee H; Seong MW; Chae JH; Park KS; Kwak SH Diabetes Metab J; 2024 May; 48(3):482-486. PubMed ID: 38311059 [TBL] [Abstract][Full Text] [Related]
18. Diabetes and nephrotic syndrome: Answers. Gilbert RD; Hind E; Vadgama B Pediatr Nephrol; 2017 Oct; 32(10):1887-1889. PubMed ID: 28012006 [No Abstract] [Full Text] [Related]
19. Mitochondrial DNA mutation "m.3243A>G"-Heterogeneous clinical picture for cardiologists ("m.3243A>G": A phenotypic chameleon). Niedermayr K; Pölzl G; Scholl-Bürgi S; Fauth C; Schweigmann U; Haberlandt E; Albrecht U; Zlamy M; Sperl W; Mayr JA; Karall D Congenit Heart Dis; 2018 Sep; 13(5):671-677. PubMed ID: 30133155 [TBL] [Abstract][Full Text] [Related]
20. Autonomic symptoms in carriers of the m.3243A>G mitochondrial DNA mutation. Parsons T; Weimer L; Engelstad K; Linker A; Battista V; Wei Y; Hirano M; Dimauro S; De Vivo DC; Kaufmann P Arch Neurol; 2010 Aug; 67(8):976-9. PubMed ID: 20697048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]